Vistagen Therapeutics Inc (VTGN) Q3 2025 Earnings Call Highlights: Promising Trial Results and ... [Yahoo! Finance]
VistaGen Therapeutics, Inc. (VTGN)
Last vistagen therapeutics, inc. earnings: 2/13 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vistagen.com
Company Research
Source: Yahoo! Finance
3 min read In This Article VTGN Release Date: February 13, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Vistagen Therapeutics Inc ( NASDAQ:VTGN ) reported positive results from their Palisade 2 Phase 3 trial for the acute treatment of social anxiety disorder (SAD) with their lead product candidate, fasinol. The company has initiated Palisade 3 and Palisade 4 Phase 3 trials, which are advancing towards expected top-line results later this year. Vistagen is exploring additional applications for their product candidates, including Iruone for major depressive disorder and PH80 for menopausal hot flashes. The company has a diverse pipeline with five clinical-stage intranasal p
Read more
Impact Snapshot
Event Time:
VTGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTGN alerts
High impacting VistaGen Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VTGN
News
- Vistagen to Present at the 2025 Anxiety and Depression Association ConferenceBusiness Wire
- Vistagen to Participate in Stifel 2025 Virtual CNS ForumBusiness Wire
- Vistagen to Participate in the 45th Annual TD Cowen Healthcare ConferenceBusiness Wire
- https://seekingalpha.com/article/4758658-vistagen-pherine-candidate-proof-of-concept-continues-with-fifth-indication [Seeking Alpha]Seeking Alpha
- Vistagen Reports Fiscal Year 2025 Third Quarter Financial Results and Corporate Update [Yahoo! Finance]Yahoo! Finance
VTGN
Earnings
- 2/13/25 - Beat
VTGN
Sec Filings
- 3/6/25 - Form 8-K
- 2/14/25 - Form SCHEDULE
- 2/14/25 - Form SCHEDULE
- VTGN's page on the SEC website